{
  "first_published_at": "2008-04-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON085181", 
  "title": "Combined oral contraceptives: prevention of ovarian cancer", 
  "tags": "{\"parsed_therapeutic\": [\"obstetrics-gynaecology-fertility\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Obstetrics, gynaecology and fertility\"]}", 
  "_document_number": 292, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/adverse_icon.png", 
  "therapeutic_area": [
    "obstetrics-gynaecology-fertility"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Combined oral contraceptives: prevention of ovarian cancer</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: April 2008</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--A new study of more than 23 000 women with ovarian cancer has confirmed that use of combined oral contraceptives (COC) reduces the risk of ovarian cancer.-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p align=\"left\">A new study<cite>Collaborative Group on Epidemiological Studies of Ovarian Cancer. Lancet 2008; 371: 303&ndash;14.</cite>of more than 23 200 women with ovarian cancer has confirmed that use of combined oral contraceptives (COC) reduces the risk of ovarian cancer. This effect increases with longer duration of use and persists for many years after stopping. The researchers estimate that about two cases of ovarian cancer and one death from the disease before age 75 years are prevented for every 5000 women-years of use of combined oral contraceptives.</p><p align=\"left\"><em>Article citation: Drug Safety Update April 2008; Vol 1, Issue 9: 10</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p align=\"left\">A new study<cite>Collaborative Group on Epidemiological Studies of Ovarian Cancer. Lancet 2008; 371: 303&#8211;14.</cite>of more than 23 200 women with ovarian cancer has confirmed that use of combined oral contraceptives (COC) reduces the risk of ovarian cancer. This effect increases with longer duration of use and persists for many years after stopping. The researchers estimate that about two cases of ovarian cancer and one death from the disease before age 75 years are prevented for every 5000 women-years of use of combined oral contraceptives.</p><p align=\"left\"><em>Article citation: Drug Safety Update April 2008; Vol 1, Issue 9: 10</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2008-04-01", 
  "date_last_modified": "2010-08-19", 
  "_assets": [], 
  "_item_id": 292, 
  "summary": "", 
  "body": "Article date: April 2008\n\nA new study[^1]of more than 23 200 women with ovarian cancer has confirmed that use of combined oral contraceptives (COC) reduces the risk of ovarian cancer. This effect increases with longer duration of use and persists for many years after stopping. The researchers estimate that about two cases of ovarian cancer and one death from the disease before age 75 years are prevented for every 5000 women-years of use of combined oral contraceptives. \n\nArticle citation: Drug Safety Update April 2008; Vol 1, Issue 9: 10\n\n[^1]: Collaborative Group on Epidemiological Studies of Ovarian Cancer. Lancet 2008; 371: 303â€“14.\n"
}